Customize your JAMA Network experience by selecting one or more topics from the list below.
Carroll AE, Bauer NS, Dugan TM, Anand V, Saha C, Downs SM. Use of a Computerized Decision Aid for Developmental Surveillance and Screening: A Randomized Clinical Trial. JAMA Pediatr. 2014;168(9):815–821. doi:10.1001/jamapediatrics.2014.464
Developmental delays and disabilities are common in children. Research has indicated that intervention during the early years of a child's life has a positive effect on cognitive development, social skills and behavior, and subsequent school performance.
To determine whether a computerized clinical decision support system is an effective approach to improve standardized developmental surveillance and screening (DSS) within primary care practices.
Design, Setting, and Participants
In this cluster randomized clinical trial performed in 4 pediatric clinics from June 1, 2010, through December 31, 2012, children younger than 66 months seen for primary care were studied.
We compared surveillance and screening practices after adding a DSS module to an existing computer decision support system.
Main Outcomes and Measures
The rates at which children were screened for developmental delay.
Medical records were reviewed for 360 children (180 each in the intervention and control groups) to compare rates of developmental screening at the 9-, 18-, or 30-month well-child care visits. The DSS module led to a significant increase in the percentage of patients screened with a standardized screening tool (85.0% vs 24.4%, P < .001). An additional 120 records (60 each in the intervention and control groups) were reviewed to examine surveillance rates at visits outside the screening windows. The DSS module led to a significant increase in the percentage of patients whose parents were assessed for concerns about their child's development (71.7% vs 41.7%, P = .04).
Conclusions and Relevance
Using a computerized clinical decision support system to automate the screening of children for developmental delay significantly increased the numbers of children screened at 9, 18, and 30 months of age. It also significantly improved surveillance at other visits. Moreover, it increased the number of children who ultimately were diagnosed as having developmental delay and who were referred for timely services at an earlier age.
clinicaltrials.gov Identifier: NCT01351077
Create a personal account or sign in to: